期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Study of Properties of Lead Selenide (PbSe) Thin Films Deposited on TiO2
1
《Journal of Energy and Power Engineering》 2013年第11期2100-2105,共6页
The study of nano properties of PbSe (lead selenide) thin films deposited on TiO2 semi conductor film prepared by sol gel method was a new work destined to perfect the nano materials used in photovoltaic energy. The... The study of nano properties of PbSe (lead selenide) thin films deposited on TiO2 semi conductor film prepared by sol gel method was a new work destined to perfect the nano materials used in photovoltaic energy. The growth of the first group of the fihns (Set 1: P(9)) & P(14)) was based on the decomposition of lead citrate and sodium selenosulphite in the presence of sodium citrate and sodium hydroxide with ammonia and triethalamine (TEA) acting as the complexing agents and P.H stabilizers; while in the second group (Set 2: Pc15~), the reaction bath was made up of solutions of lead nitrate Pb(NO3)2, PVA (polyvinyl alcohol), H20 (distilled water), NH3 (ammonia), sodium selenosulphite (Na2SeSO3) and Triethalamine [N(CH2CH2OH)], which was used as the complexing agent. The deposited materials were identified by X-ray diffraction. In addition, nano optical and morphological investigations were also performed. The sample P9 has the lowest absorbance of about 0.3 nm in the ultra-violet region. It was found that there was a reduction in the optical absorbance as the wavelength increases. The optical band gap shows a range of 1.26-2.00 eV with sample PcIs~ having the lowest direct band gap. 展开更多
关键词 Annealing temperature chemical bath technique lead selenide thin films TiO2 semi conductor transmittance nanoproperties.
下载PDF
高分子抗肿瘤纳米药物的挑战与发展 被引量:12
2
作者 孙瑞 邱娜莎 申有青 《高分子学报》 SCIE CAS CSCD 北大核心 2019年第6期588-601,共14页
抗肿瘤纳米药物的理想目标是降低毒副作用并提高疗效,但目前临床用纳米药物主要以显著降低药物毒性的优势获批进入临床.近年来,肿瘤分子靶向治疗、免疫治疗等高疗效方法的飞速发展,使提高疗效成为抗肿瘤纳米药物研究的当务之急.静脉注... 抗肿瘤纳米药物的理想目标是降低毒副作用并提高疗效,但目前临床用纳米药物主要以显著降低药物毒性的优势获批进入临床.近年来,肿瘤分子靶向治疗、免疫治疗等高疗效方法的飞速发展,使提高疗效成为抗肿瘤纳米药物研究的当务之急.静脉注射的纳米药物向实体肿瘤靶向输送过程是血液系统内循环、从血管外渗进入肿瘤组织和蓄积、肿瘤组织内渗透、肿瘤细胞内吞、胞内药物释放的五步'级联'递送过程(即CAPIR cascade).因此,如何设计载体高分子的功能,赋予纳米药物随血液系统、肿瘤组织和肿瘤细胞的微环境的变化而改变其纳米尺寸(size)、表面(surface)和稳定性(stability)(即3S nanoproperty transitions),从而满足肿瘤靶向输送过程中各步的要求以确保每一步具有高的效率,是获得高肿瘤靶向输送效率和高疗效的关键.本文将介绍利用各种响应高分子包括作者提出的电荷反转型高分子来设计具有上述3S纳米特性转换能力的高效纳米药物的方法,并总结了今后高分子纳米药物研究面临的挑战和发展趋势. 展开更多
关键词 纳米药物 功能高分子 肿瘤靶向输送 纳米特性转换 治疗性高分子 分子纳米药物
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部